Known by acronyms that need no explanation, viruses like COVID, SARS and Ebola conjure images of medics in protective suits and spark fear in populations worldwide.
Vaccines for individual viruses have provided some relief, but new strains pose a constant challenge.
Now, new AI-aided vaccine technology developed by scientists at Cambridge University offers potential immunity against whole families of viruses and could even prevent the next pandemic, according to researchers.
Ma et al. present a pan-cancer analysis of 61 cancers that defines a TP53-based tripartite classification: TP53_top, TP53_plus, and Non_TP53. Analysis of 80,524 mutations and network integration reveals mutational heterogeneity, dysregulated transcription factor regulatory networks, and signaling pathway networks, providing a framework for precision oncology.
A Monash University-led study has found that an unusual pairing of two commonly used antibiotics can kill and stop the spread of resistance in a highly drug-resistant bacterium, Pseudomonas aeruginosa, which can cause life-threatening bloodstream infections, pneumonia and meningitis.
Published in The Lancet Microbe, Monash Institute of Pharmaceutical Sciences (MIPS) researchers used a validated laboratory infection system in which they were able to expose bacterial samples from infected patients to simulated antibiotic dosing regimens, as would actually occur in hospitalized patients.
The discovery of the combination regimen of two so-called β-lactam antibiotics—the most commonly used antibiotic class against serious infections—comes in the context of the World Health Organization’s designation of Pseudomonas aeruginosa as a high-priority pathogen requiring rapid and sustained action.
Every echocardiogram is a moving story. For a baby born with a complex heart condition, the gray and black images on the ultrasound screen can influence some of the earliest and most important decisions a medical team makes: What exactly is wrong with the heart? How urgent is surgery? What should doctors watch for after repair?
In our recent work, we focused on tetralogy of Fallot, often shortened to TOF. It is one of the most common cyanotic congenital heart defects. The condition involves several structural abnormalities of the heart, and many children with TOF need careful evaluation, surgery and long-term follow-up. The research is published in the journal eBioMedicine.
Echocardiography is central to that process. It is widely used, noninvasive and rich in clinical information. But it is also demanding. Clinicians must identify the correct views, interpret moving images, measure small cardiac structures, and combine these pieces of information with the patient’s clinical course. Even experienced clinicians can face heavy workloads, and interpretation can vary between observers.
Spread the love Eliminating sugar from your diet may be more detrimental than previously thought, according to an animal study presented at ENDO 2026, the Endocrine Society’s annual meeting in Chicago. Completely removing sucrose from a low-fat diet may unexpectedly disrupt gut health and promote inflammation and metabolic dysfunction, highlighting that balanced nutrition is more important…
Is this the most controversial biotech advancement yet? 🧠 Inside this sneak peek of Mattcast #567, we break down a groundbreaking medical tech company testing on bodiless heads for neurological research.
New standard video episodes drop weekly! Hit follow to never miss a breakdown of the wildest advancements in future science and tech news.
#Biotech #MedicalTech #FutureScience #Mattcast #Neurology #TechNews #Walljangers #TechPodcast #Neuroscience #BiotechNews #SciFiTech
What if aging isn’t just biology…but also psychology — and your brain is quietly shaping how fast you age every day?
Dr. Srini Pillay, MD (https://drsrinipillay.com/) is a Harvard-trained psychiatrist, brain researcher, entrepreneur, author, and expert in the science of human potential, resilience, and longevity.
Dr. Pillay previously served as Assistant Professor of Psychiatry at Harvard Medical School and directed both the Outpatient Anxiety Disorders Program and the Panic Disorders Research Program in Brain Imaging at McLean Hospital, one of the world’s leading psychiatric institutions.
Over the course of his career, Dr. Pillay has focused on understanding how the brain shapes performance, creativity, emotional health, leadership, and even biological aging. His work bridges neuroscience, psychiatry, technology, and human behavior — translating cutting-edge brain science into practical tools for individuals, organizations, and healthcare systems.
Dr. Pillay is the co-founder and Chief Medical Officer of Reulay (https://www.reulay.com/), an AI-driven digital therapeutics and mindset technology company focused on healthy longevity, stress reduction, and human performance. He is also founder of the NeuroBusiness Group (https://nbgcorporate.com/), where he works with leaders and organizations around the world on brain-based approaches to innovation, adaptability, resilience, and navigating complexity in the age of AI.
Dr. Pillay is the author of several influential books including Tinker Dabble Doodle Try (https://www.amazon.com/Tinker-Dabble-?tag=lifeboatfound-20… which explores the neuroscience of creativity and the untapped power of the brain’s unconscious processing systems.
She says she reversed 20 years of biological aging by testing gene therapy on her own body before anyone else. In this episode of The 200 Year Life Project, Gary Leland sits down with Elizabeth Parrish, founder and CEO of BioViva, the first person to undergo gene therapy specifically aimed at reversing aging.
Gary, 71 and dead serious about reaching 200, talks with Parrish about how telomere and myostatin gene therapy works, what her published telomere data showed, why these therapies are still done outside the US, and how she believes affordable gene therapy could change human lifespan and healthspan. They also get into longevity escape velocity, the \.
“You have many different cells playing different parts,” said Dr. Dino Di Carlo, the Armond and Elena Hairapetian Professor and Chair of Bioengineering at the UCLA Samueli School of Engineering. “A healthy tissue emerges when those parts are coordinated — when cells listen and respond to one another in the right way.”
But when those signals are misheard or go out of sync, the results can be devastating. In fibrosis, a misfiring message drives cells into a scar-producing overdrive, stiffening lungs, hearts and kidneys. In cancer, tumor cells can distort the score, sending molecular signals that suppress or misdirect immune attack. What sounds like harmony in health can become discord in disease.
Now, in a perspective published in Nature Biotechnology, Di Carlo and colleagues from UCLA, USC and Caltech are calling on the scientific community to join the Billion Cell×Cell Project — an effort to understand the cellular symphony one duet at a time, by systematically mapping how individual pairs of cells influence one another.
Avian leukosis viruses (ALVs) include a group of avian retroviruses primarily associated with neoplastic diseases in poultry, commonly referred to as avian leukosis. Belonging to different subgroups based on their envelope properties, ALV subgroups A, B, and J (ALV-A, ALV-B, and ALV-J) are the most widespread in poultry populations. Early identification and removal of virus-shedding birds from infected flocks are essential for the ALVs’ eradication. Therefore, the development of rapid, accurate, simple-to-use, and cost effective on-site diagnostic methods for the detection of ALV subgroups is very important. Cas13a, an RNA-guided RNA endonuclease that cleaves target single-stranded RNA, also exhibits non-specific endonuclease activity on any bystander RNA in close proximity.